Alzheimers and Parkinsons Diseases

Alzheimer's is a chronic neurodegenerative disorder that usually starts slowly and worsens with time and is the most common cause of dementia. As this disorder advances, symptoms can include problems with language, disorientation, mood swings, motivation is lost, self-care management becomes difficult and other behavioural issues. Speed of progression of Alzheimer’s vary, the typical life expectancy following diagnosis is three to nine years.

Alzheimer disease conferences provide information regarding  current research and trends in Alzheimer’s disease. The main topics discussed in conference Dementia vs. Alzheimer’s, Alzheimer's and the brain, Diagnosis and symptoms, the role of plaques and tangles, Research and progress, Alzheimer’s medication, Alzheimer’s imaging and clinical trials, Alzheimer’s pathophysiology, Use Of Animal Models, Pharmacological Studies.

Statistics:
Alzheimer’s is the sixth most common cause of death according to the Centres for Disease Control and Prevention(CDC)  among U.S adults. It ranks fifth among causes of death for people 65 years and older. In a study it was found that in 2010 there were 4.7 million Americans over the age of 65 years suffering with Alzheimer’s disease. Researchers projected that there will be 13.8 million Americans with Alzheimer’s by 2050. According to CDC’s estimations over 90 percent of people with Alzheimer’s don’t see any symptoms until they are over 60 years old. As per the CDC about $259 billion was spent on Alzheimer’s and dementia care costs in the United States in 2017. The global market for Alzheimers and diagnostics by reach should reach over $6.2 billion by 2020.

Parkinson's disease is a neurodegenerative disorder that have an effect on predominately dopamine-producing (“dopaminergic”) neurons in a specific area of the brain called substantia nigra. Symptoms normally develop slowly over years. The development of symptoms is often different from one person to another due to the diversity of the disease. People with Parkinson’ may experience: Tremor, mainly at rest and described as pill rolling tremor in hands. Other forms of tremor are possible Bradykinesia, Limb rigidity, Gait and balance problems.

These are the key topics that are discussed in Alzheimers disease conferences:
Dementia vs. Alzheimer’s, Alzheimer's and the brain, Diagnosis and symptoms, the role of plaques and tangles, Research and progress, Alzheimer’s medication, Alzheimer’s imaging and clinical trials, Alzheimer’s pathophysiology, Use Of Animal Models, Pharmacological Studies.

Parkinson disease, causes, symptoms, Parkinson pathophysiology, Epidemiology of Parkinson’s disease, Neurocognitive and Neuromuscular Disorders,  Risk Factors of Parkinsons disease, Diagnostic and Neuroimaging for Parkinsons Disease,   Managing life with Parkinsons disease, Novel therapeutics for Parkinsons disease, Clinical Trials in Parkinsons disease, Deep brain stimulation

Target Audience :

Neuroscientists, Neurologists, Directors, Physicians, Researchers, Professors, Industrial Experts, Neurosurgeons, Psychiatrist, Nutritional Scientists, Lecturers and Students

Tags :

neurology,neurology2021,neurologyconference,neurologycongress,neuroscience,neuroscienceconference,neuroscience2021,neurosciencecongress,dementiaconference,neurologymeetings,neurologysummit,neuroscienceconferences,dementiacongress,neurologyeurope,neurologistconference,neuroscientist,dementia,alzheimersdisease

Get In Touch

Venue

Hotel NH Valencia Center, Valencia, Spain

Call Us

+1 4693420402
Abstract Deadline
30/04/2020